A space to discuss commonly reported semaglutide side effects and tolerability, without diagnosing symptoms or giving treatment instructions.
Commonly reported issues
- Gastrointestinal effects — nausea, vomiting, diarrhea, and constipation are the most frequently reported adverse events across semaglutide’s trials
- Appetite suppression — an expected pharmacological effect of GLP-1 receptor activity
- Fatigue — reported by some participants, particularly during dose escalation
- Injection or administration-related effects — for the oral tablet, timing relative to food and other medications is commonly discussed
- Exercise tolerance — some members and researchers have noted temporary changes during periods of reduced caloric intake
Published vs. anecdotal
The list above reflects patterns reported in published trial safety data. If you’re sharing your own experience, please frame it as personal — not as a general claim about what everyone should expect.
If you’re experiencing severe or concerning symptoms, please seek care from a licensed healthcare professional. This thread is for educational discussion, not urgent-care advice, diagnosis, or a substitute for medical evaluation.
